42 reports of this reaction
2.0% of all TAZAROTENE reports
#10 most reported adverse reaction
ACNE is the #10 most commonly reported adverse reaction for TAZAROTENE, manufactured by Almirall, LLC. There are 42 FDA adverse event reports linking TAZAROTENE to ACNE. This represents approximately 2.0% of all 2,077 adverse event reports for this drug.
Patients taking TAZAROTENE who experience acne should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ACNE is a less commonly reported adverse event for TAZAROTENE, but still significant enough to appear in the safety profile.
In addition to acne, the following adverse reactions have been reported for TAZAROTENE:
The following drugs have also been linked to acne in FDA adverse event reports:
ACNE has been reported as an adverse event in 42 FDA reports for TAZAROTENE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ACNE accounts for approximately 2.0% of all adverse event reports for TAZAROTENE, making it a notable side effect.
If you experience acne while taking TAZAROTENE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.